Search results
Merck to Acquire EyeBio
New Jersey Business Magazine· 20 hours agoMerck, through a subsidiary, announced today that it will acquire all outstanding shares of EyeBio for up to $3 billion, including an upfront payment of...
Merck Reaches $1.3 Billion Deal for Eye-Drug Company EyeBio
The Wall Street Journal· 16 hours agoHEALTH NEWS Merck has struck a $1.3 billion deal to buy Eyebiotech, a move that would push the big...
Merck acquires EyeBio in up to $3B deal By Proactive Investors
Investing.com· 7 hours agoMerck & Co Inc (NYSE:MRK, ETR:6MK) announced it is acquiring Eyebio, a privately held...
Medical Stock Soars On Takeover; But Merck Unmoved On $3 Billion Get
Investor's Business Daily· 11 hours agoSurmodics, which makes components for medical devices and tests, agreed to a $627 million takeover...
Merck To Pay as Much as $3 Billion for Eye Treatment Startup
Bloomberg· 16 hours agoHave a confidential tip for our reporters? Merck & Co. restocked its cabinet of eye treatments with...
Merck's Multi-Billion Cancer Drug Keytruda Aces Late-Stage Breast Cancer Study (UPDATED)
Benzinga via Yahoo Finance· 1 day agoEditor’s Note: The title of the story is updated to correct the reference to ‘Breast’ cancer instead...
Merck Reportedly Nearing $1.3B Acquisition Of EyeBio To Expand Eye-Care Market Presence - Merck & Co...
Benzinga· 18 hours agoMerck & Co., Inc. MRK is reportedly on the verge of acquiring EyeBio, an eye drug company, for a sum...
Merck to Buy Eye Drug Company Eyebiotech for Up to $3 Billion. It’s Doubling Down on Deals.
Barrons.com· 14 hours agoThe pharmaceutical company agrees to buy eye drug company Eyebiotech for up to $3 billion as it...
Merck nears $1.3 billion cash deal for eye-drug company EyeBio, WSJ reports
Reuters via Yahoo Finance· 1 day agoMerck has said it's in the market for deals of up to around $15 billion as it plans ways to deal...
Merck to acquire EyeBio in potential $3B deal
NJBIZ· 12 hours agoOn Wednesday morning, Rahway-headquartered Merck announced it will acquire EyeBio in a deal that has a potential value of $3 billion. The agreement will bring EyeBio into ...
